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Abstract
Superﬁcial wound complications have been consistently implicated in the development of prosthetic joint infection. This cohort study aimed
to determine perioperative risk factors associated with superﬁcial wound complications. The study was performed over an 18-month
period (January 2011 to June 2012) and included 964 patients undergoing prosthetic hip or knee replacement surgery. The factors
associated with superﬁcial wound complication differed according to arthroplasty site. In the combined cohort the following factors were
associated with superﬁcial wound complications: the use of 0.5% chlorhexidine in 70% alcohol for surgical skin preparation compared with
1% iodine in 70% alcohol (odds ratio (OR) 4.75; 95% conﬁdence interval (CI) 1.42, 15.92; p = 0.012); increasing age (OR, 1.13; 95% CI,
1.06,1.19; p 0.18); increasing body mass index (BMI) (OR, 1.08; 95% CI, 1.05,1.12; p < 0.001); rheumatoid arthritis (OR, 2.56; 95% CI, 1.17,
5.58; p 0.018); and increasing blood transfusions (OR, 1.26; 95% CI, 1.06,1.49; p 0.008). In the hip arthroplasty cohort, the use of 0.5%
chlorhexidine in 70% alcohol for surgical skin preparation (OR, 13.35; 95% CI, 2.11, 84.29; p 0.006), increasing BMI (OR, 1.13; 95% CI, 1.06,
1.19; p < 0.001) and increasing blood transfusions (OR, 1.26; 95% CI, 1.06, 1.49; p 0.008) were associated with superﬁcial
wound complications. In the knee arthroplasty cohort rheumatoid arthritis (OR, 2.75; 95% CI, 1.03, 7.33; p 0.043) and increasing
tourniquet time (OR, 1.01; 95% CI, 1.00, 1.02; p = 0.029) were independent predictors of superﬁcial wound complications. Further
research is warranted to assess the impact of modiﬁcation of these factors on the subsequent development of wound complications and
prosthetic joint infection.
Keywords: Arthroplasty, prosthetic joint infection, superﬁcial incisional surgical site infection, superﬁcial wound complications
Original Submission: 23 January 2013; Revised Submission: 24 February 2013; Accepted: 24 February 2013
Editor: M. Paul
Article published online: 7 March 2013
Clin Microbiol Infect 2014; 20: 130–135
10.1111/1469-0691.12209
Corresponding author: Dr T. Peel, St Vincent’s Hospital
Melbourne, Department of Orthopaedics, 3rd Floor, Daly Wing, PO
Box 2900, Fitzroy, Victoria 3065, Australia
E-mail: tnpeel@unimelb.edu.au
Introduction
Prosthetic joint surgery has led to improvement in symptoms
of osteoarthritis and patient’s quality of life. The popularity of
this surgery continues to increase worldwide, including in
Australia [1]. Data from epidemiological studies estimate that
the number of knee and hip arthroplasties will increase to 4.5
million procedures per year by 2030 in the United States of
America [2]. Infective complications of the prosthesis occur in
1–3% of patients undergoing hip and knee arthroplasty;
however, they can have catastrophic consequences and often
result in patient morbidity and signiﬁcant cost to the public
healthcare system [3]. In addition to the direct complications
of infection, the need for treatment with antibiotics contrib-
utes to emerging antimicrobial resistance [4]. Superﬁcial
wound complications, such as surgical site infection (SSI) and
prolonged wound discharge, have been consistently implicated
in the development of prosthetic joint infection and may
increase the risk of subsequent deep infection by up to 35-fold
[5,6]. While there are a number of epidemiological studies
examining risk factors for deep prosthetic infections in hip and
knee arthroplasty, risk factors for superﬁcial wound compli-
cations are not as well established.
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The aims of this study were (i) to describe the incidence and
severity of superﬁcial wound complications in a cohort of
patients undergoing hip and knee arthroplasty and (ii) to
elucidate perioperative factors associated with the develop-
ment of superﬁcial wound complications.
Patients and Methods
Study setting and population
This retrospective cohort study was performed at St Vincent’s
Hospital Melbourne (SVHM), Victoria, Australia, an 848-bed
tertiary public hospital. This centre comprises 16 orthopaedic
surgeons performing over 800 prosthetic hip and knee
replacements per year. All hospital postoperative care is
performed according to the SVHM Hip or Knee Replacement
Clinical Pathway, which has been described previously [7]. All
patients received antibiotic prophylaxis, in keeping with
national guidelines, prior to skin incision and >5 min prior to
tourniquet inﬂation [8]. The study was performed over an
18-month period (January 2011 to June 2012) and included all
patients undergoing elective primary and revision hip and knee
arthroplasty during this period, as systematically recorded in a
database prospectively compiled by the Department of
Orthopaedics [9]. Patients were excluded if they underwent
arthroplasty for fractured neck of femur, or revision arthro-
plasty with prior history of septic arthritis affecting the index
joint, or if they were lost to follow-up. Patients were
followed-up from the date of index arthroplasty until review
in the orthopaedic clinic 6 weeks post-surgery. The study
design was reviewed and approved by the SVHM Human
Research Ethics Committee.
Deﬁnitions
Superﬁcial wound complication was recorded if the patient
developed either a superﬁcial incisional SSI or prolonged
wound ooze in the 30 days following index arthroplasty
surgery.
Superﬁcial incisional SSI was deﬁned as per the US Centers
for Diseases Control and Prevention (CDC) Criteria [10,11].
In keeping with the US CDC criteria, a superﬁcial incisional SSI
was not recorded in the case of stitch abscess, navigation pin
site infection, cellulitis not in communication with the wound,
or in the case that a general practitioner commenced
antibiotics for ‘swelling’, ‘erythema’ or ‘increased pain’, which
was not subsequently recognized as a superﬁcial incisional SSI
by the orthopaedic surgeon or treating physician [10].
Prolonged wound ooze was deﬁned if there was docu-
mented drainage from the surgical incision that required
intervention, such as superﬁcial surgical debridement, or if it
led to deviation from normal care as per the SVHM
arthroplasty clinical pathway, such as delayed discharge from
hospital [12].
A data collection spreadsheet was designed to document
potential risk factors for superﬁcial wound complications.
Risk factors were drawn from the current literature as well
as novel, biologically plausible risk factors and included
patient co-morbidities and factors surrounding operative and
postoperative care. Information was extracted from the
database and from careful medical chart review by a single
researcher (KC). Information regarding postoperative com-
plications was obtained primarily from orthopaedic clinic
notes, as well as emergency department or medical record
entries if readmission occurred. All management strategies
and decisions were not randomized and were based on the
treating surgeon’s preference at the time of surgery. There
was no telephone or recall contact with patients for the
purposes of this study.
Statistical analysis
Descriptive statistics were used to summarize and report the
data. Descriptive analyses were based on percentages and
frequencies for categorical variables and for continuous
variables, mean and standard deviation (SD) or medians and
interquartile range (IQR) if the data were skewed. Logistic
regression was performed to produce odds ratios (ORs) with
95% conﬁdence intervals (CIs) for the association between
each variable and the presence or absence of superﬁcial wound
complication. Multivariable logistic regression techniques were
used in the assessment of risk factors by adding in forward
substitution factors identiﬁed as signiﬁcant in the univariate
analysis (p value <0.1) or risk factors previously identiﬁed in
the published literature. Fisher’s exact test was performed to
compare rates of superﬁcial wound complication and pros-
thetic joint infection. All reported p-values were two-tailed
and for each analysis p < 0.05 was considered statistically
signiﬁcant. All analyses were performed using Stata 11.2
(StataCorp, College Station, TX, USA, 2009).
Results
Over the 18-month study period, 1006 patients underwent
prosthetic hip or knee replacement surgery at SVHM.
Forty-two patients were excluded from the study (eight with
fractured neck of femur, 12 with septic revision arthroplasty
and 22 who were lost to follow-up). Therefore, 964 patients
were included in this current study (453 hip and 511 knee
arthroplasties). The demographic characteristics of the
cohorts are outlined in Table 1.
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Hip and knee cohorts were analysed as a combined cohort
and then separately. Overall, 88 (9%) patients developed a
superﬁcial wound complication (42 had superﬁcial incisional
SSI, 40 had prolonged wound discharge and six had both).
Combined cohort
The combined cohort results of the univariate and multivariate
logistic regression analysis are outlined in Table 2. On
univariate analysis, the following factors were associated with
the development of a superﬁcial wound complication: increas-
ing age, increasing body mass index (BMI), rheumatoid
arthritis, warfarin, the use of 0.5% chlorhexidine in 70%
alcohol for surgical skin preparation prior to surgical incision
compared with 1% iodine in 70% alcohol, blood transfusion
and skin closure with staples rather than sutures. On
multivariate analysis, the following factors were independently
associated with the development of superﬁcial wound compli-
cations: increasing age, increasing BMI, rheumatoid arthritis,
skin preparation with 0.5% chlorhexidine in 70% alcohol and
increasing number of units of blood transfused in the
postoperative period.
Hip cohort
In the cohort of 453 patients who underwent elective hip
arthroplasty, a wound complication occurred in 43 patients at
a rate of 9%. Readmission to hospital for management of the
wound complication was necessary in 11 of these cases (26%).
In the univariate analysis of hip arthroplasty patients, the
following factors were associated with superﬁcial wound
complication: increasing BMI, use of 0.5% chlorhexidine in
70% alcohol for surgical skin preparation, blood transfusion
and warfarin therapy. On multivariate analysis increasing BMI,
skin preparation with 0.5% chlorhexidine in 70% alcohol and
increasing blood transfusion requirements predicted superﬁ-
cial wound complications (Table 3).
Knee cohort
In the cohort of 511 knee arthroplasty patients, a wound
complication occurred in 45 patients at a rate of 9%.
Readmission to hospital for management of the wound
complication was necessary in 15 of these cases (33%). The
following factors were identiﬁed on univariate analysis: rheu-
matoid arthritis, diabetes mellitus and increasing tourniquet
time. On multivariate analysis, rheumatoid arthritis and
increasing tourniquet time predicted superﬁcial wound com-
plications (Table 4).
Prosthetic joint infection
Over the course of the study, 14 patients presented with
prosthetic joint infection (seven prosthetic hip and seven
prosthetic knee infections), with an overall infection rate of
1.45%. In prosthetic hip infections, six patients had preceding
superﬁcial wound complications (Fisher’s exact test p < 0.001).
TABLE 1. Demographic characteristics of the hip and knee
arthroplasty cohorts
Variable
Hip cohort,
n = 453
Knee cohort,
n = 511
Median age, years (IQR) 69 (60, 75) 70 (64, 76)
Median BMI, kg/m2 (IQR) 29.7 (26.2, 33.7) 33.7 (29.6, 38.4)
Female gender 272 (60%) 335 (66%)
Rheumatoid arthritis 19 (4%) 39 (8%)
Immunosuppressant medications 10 (2%) 32 (6%)
Systemic corticosteroids 13 (3%) 25 (5%)
Diabetes mellitus 58 (13%) 118 (23%)
Preoperative prescription of warfarin 28 (6%) 47 (9%)
American Society of Anaesthesiologists (ASA) score
1 15 (3%) 12 (2%)
2 25512 (2%) 249 (49%)
3 171 (38%) 233 (46%)
4 12 (3%) 17 (3%)
Surgical antibiotic prophylaxis
Cefazolin 437 (96%) 483 (96%)
Vancomycin 12 (3%) 22 (4%)
Gentamycin 345 (76%) 395 (77%)
Image guided surgery (IGS) – 94 (18%)
Tourniquet – 485 (95%)
Median tourniquet time, minutes (IQR) – 75 (60, 90)
Median operation time, minutes (IQR) 100 (85, 115) 95 (85, 115)
Wound closure
Staples 324 (72%) 397 (81%)
Subcuticular sutures 123 (28%) 94 (19%)
Presence of drain tube 165 (36%) 262 (51%)
Median drain output in mL (IQR) 250 (140, 400) 380 (140, 700)
Median transfusion, units (range) 0 (0, 8) 0 (0, 7)
Surgical skin preparation
1% iodine in 70% alcohol 447 (99%) 501 (98%)12
0.5% chlorhexidine in 70% alcohol 6 (1%) 9 (2%)
TABLE 2. Univariate and multivariate analysis of risk factors
for superﬁcial wound complications in the combined cohort
Variable
Univariate analysis Multivariate analysis
OR (95% CI)
p
value OR (95% CI)
p
value
Age, years 1.02 (1.00, 1.05) 0.044 1.03 (1.00, 1.06) 0.018
Female gender 0.98 (0.62, 1.54) 0.9
Prosthetic hip
replacement
Reference –
Prosthetic knee
replacement
0.92 (0.59, 1.43) 0.7
BMI, kg/m2 1.06 (1.02, 1.09) 0.001 1.08 (1.05, 1.12) <0.001
Warfarin 2.04 (1.05, 3.94) 0.035
Rheumatoid arthritis 1.97 (0.93, 4.15) 0.077 2.56 (1.17, 5.58) 0.018
Immunosuppressant
medication
2.08 (0.89, 4.82) 0.089
Systemic
corticosteroids
1.93 (0.78, 4.75) 0.2
Diabetes mellitus 1.36 (0.80, 2.30) 0.3
Surgical skin preparation
1% iodine in
70% alcohol
Reference –
0.5% chlorhexidine
in 70% alcohol
3.74 (1.17, 12.0) 0.027 4.75 (1.42, 15.92) 0.012
Wound closure
Staples Reference –
Subcuticular sutures 0.50 (0.27, 0.95) 0.033 0.54 (0.29, 1.03) 0.063
Operation time (min) 1.00 (0.99, 1.01) 0.8
Presence of drain tube 0.95 (0.61, 1.48) 0.8
Drain loss (mL) 0.99 (0.99, 1.00) 0.8
Blood transfusion
(units of red
blood cells)
1.24 (1.06, 1.44) 0.006 1.26 (1.06, 1.49) 0.008
Likelihood ratio = 39.90.
Overall model performance p < 0.0001.
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In prosthetic knee infections, four patients had preceding
superﬁcial wound complications (Fisher’s exact test p 0.006).
Discussion
Epidemiological studies have consistently implicated superﬁcial
wound complications in the development of deep prosthetic
joint infection [5,13]. Indeed, in this study 71% of patients
subsequently diagnosed with prosthetic joint infection had
preceding superﬁcial wound complications. We postulate that
identiﬁcation and modiﬁcation risk factors for superﬁcial
wound complications will lead to a decrease in the incidence
of subsequent deep prosthetic joint infection. In addition,
superﬁcial wound complications themselves are associated
with patient morbidity and cost to the healthcare system
independent of the development of deep infection, such as
prolonged hospital stay, readmission, ongoing treatments and
reduced patient satisfaction [5,6,14,15]. In this study, 9% of
patients developed a superﬁcial wound complication and of
these, 30% required readmission to hospital for management.
This study has identiﬁed a number of novel and clinically
relevant risk factors for superﬁcial wound complications. In
addition, this study has highlighted the risk factors that differ
according to arthroplasty site.
The optimal agent for surgical skin preparation is a
controversial issue. In a large, multicentre randomized clinical
trial in clean-contaminated surgery, skin preparation with 2%
chlorhexidine gluconate and 70% isopropyl alcohol was
associated with a reduced number of superﬁcial and deep SSIs
when compared with 10% povidone-iodine [16]. This study did
not include a third comparator arm with povidone-iodine
combined with alcohol; therefore it is difﬁcult to attribute the
reduction in SSIs to the chlorhexidine, the alcohol or to the
combination of both agents [17]. At SVHM either chlorhex-
idine with alcohol or iodine with alcohol are recommended for
skin antisepsis as per the hospital infection control recom-
mendations and the decision about which speciﬁc agent is used
is based on the surgeon’s preference. In this current study,
surgical skin preparation with chlorhexidine 0.5% in alcohol
70% was associated with a ﬁve-fold increased risk of superﬁcial
wound complications compared with iodine 1% in alcohol 70%.
The association was particularly marked in the hip arthroplasty
cohort, with a 13-fold increased risk. This association may
reﬂect differing anti-infective properties of the agents. Counter
to this, it may be argued that the difference observed reﬂects
the surgeon’s preference and surgical experience. The agents
chosen in this study differed from the randomized control trial;
however, this study raises interesting questions regarding
surgical preparation choice that requires further evaluation.
TABLE 3. Univariate and multivariate analysis of risk factors
for superﬁcial wound complications in the hip arthroplasty
cohort
Variable
Univariate analysis Multivariate analysis
OR (95% CI)
p
value OR (95% CI)
p
value
Age, years 1.02 (0.99, 1.06) 0.1
Female gender 1.26 (0.64, 2.49) 0.5
BMI 1.12 (1.06, 1.18) <0.001 1.13 (1.06¸ 1.19) <0.001
Warfarin 3.96 (1.57, 10.00) 0.004 2.93 (0.99, 8.63) 0.050
Rheumatoid
arthritis
1.31 (0.29, 5.89) 0.7
Immunosuppressant
medications
2.66 (0.55, 12.99) 0.2
Systemic
corticosteroids
1.92 (0.41, 9.00) 0.4
Diabetes mellitus 0.74 (0.25, 2.16) 0.6
Surgical skin preparation
1% iodine in
70% alcohol
Reference – – –
0.5%
chlorhexidine
in 70% alcohol
11.08 (2.16, 56.86) 0.004 13.35
(2.11, 84.29)
0.006
Wound closure
Staples Reference –
Subcuticular
sutures
0.44 (0.18, 1.07) 0.070
Operation
time (min)
1.00 (0.99, 1.01) 0.8
Presence of
drain tube
1.85 (0.96, 3.55) 0.07
Drain loss (mL) 0.99 (0.99, 1.00) 0.7
Blood transfusion
(units of red
blood cells)
1.32 (1.09, 1.60) 0.005 1.37 (1.10, 1.70) 0.005
Likelihood ratio = 37.26.
Overall model performance p < 0.0001.
TABLE 4. Univariate and multivariate analysis of risk factors
for superﬁcial wound complications in the knee arthroplasty
cohort
Variable
Univariate analysis Multivariate analysis
OR (95% CI)
p
value OR (95% CI)
p
value
Age, years 1.02 (0.98, 1.05) 0.4
Female gender 0.85 (0.45, 1.61) 0.6
BMI 1.03 (0.98, 1.08) 0.2
Warfarin 1.26 (0.47, 3.37) 0.6
Rheumatoid arthritis 2.50 (1.03, 6.04) 0.042 2.75 (1.03, 7.33) 0.043
Immunosuppressant
medication
2.03 (0.74, 5.57) 0.2
Systemic corticosteroids 2.07 (0.68, 6.31) 0.2
Diabetes mellitus 1.57 (0.80, 3.07) 0.1 2.03 (0.99, 4.16) 0.054
Surgical skin preparation
1% iodine in
70% alcohol
Reference –
0.5% chlorhexidine
in 70% alcohol
1.29 (0.16, 10.6) 0.8
Wound closure
Staples Reference –
Subcuticular sutures 0.64 (0.26, 1.57) 0.3
IGS 1.30 (0.62, 2.73) 0.5
Tourniquet 2.94 (0.33, 18.85) 0.6
Tourniquet time (min) 1.01 (1.00, 1.02) 0.029 1.01 (1.00, 1.02) 0.029
Operation time (min) 1.00 (0.99, 1.01) 0.9
Presence of drain tube 0.60 (0.32, 1.13) 0.1
Drain loss (mL) 1.00 (0.99, 1.00) 0.5
Blood transfusion
(units of red
blood cells)
1.08 (0.82, 1.43) 0.6
Likelihood ratio = 10.99.
Overall model performance p 0.012.
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Obesity has been previously implicated in prosthetic joint
infections, particularly in hip arthroplasty patients [9,18,19]. In
addition, obesity is a risk factor for prolonged postoperative
wound drainage [20]. There are a number of potential
explanations for the association between increasing BMI and
superﬁcial wound complications, including the need for larger
surgical incision, increased incidence of fat necrosis and
prolonged or more complicated arthroplasty surgery [9,20].
Rheumatoid arthritis leads to impaired immune function and
previous studies have suggested interplay between the under-
lying disease process as well as use of immunosuppressant
medications [21,22]. In this study, the use of systemic
corticosteroids or other immunosuppressant medications
was not associated with the development of superﬁcial wound
complications, suggesting the importance of impaired immunity
secondary to the underlying inﬂammatory process itself. The
association between rheumatoid arthritis and superﬁcial
wound complications varied with the joint replaced. Rheuma-
toid arthritis was implicated in knee but not hip arthroplasty.
Patients with rheumatoid arthritis have an increased rate of
carriage of Staphylococcus aureus and this organism is isolated in
a higher proportion of prosthetic joint infections in patients
with rheumatoid arthritis compared with other patients
[21,23]. We postulate that the association between rheuma-
toid arthritis and superﬁcial wound complications may repre-
sent interplay between increased Staphylococcus aureus carriage
and the overall vulnerability of the prosthetic knee joint to
infective complications [21,24].
Blood transfusion has been previously identiﬁed as a risk
factor for wound infection in surgical patients, including those
having orthopaedic surgery [25,26]. This association may
reﬂect more prolonged or complicated surgery with increased
intraoperative blood loss, or development of haematoma.
Haematoma formation impairs healing by increasing wound
tension and reducing tissue perfusion, as well as acting as a
culture medium for pathogens [6,27]. Overall, this ﬁnding
argues for strategies to minimize intraoperative blood loss,
including attention to haemostasis and drainage of the surgical
ﬁeld.
In this knee arthroplasty cohort, an increase in tourniquet
time was associated with the development of superﬁcial
wound complications. This ﬁnding is in keeping with other
published studies; increased tourniquet time has been
identiﬁed as a risk factor for deep infection and for
impaired wound healing and prolonged wound discharge
after total knee arthroplasty [28]. The reason for this effect
of increased tourniquet time may relate to a number of
factors. Firstly, the prolonged tourniquet application may
lead to local inﬂammation and tissue hypoxia and subsequent
compromised wound healing. In addition, a number of
studies have implicated tourniquet use in increased total
postoperative blood loss [29,30]. Finally, the use of the
tourniquet reduces the tissue concentrations of prophylactic
antibiotics, such as cephazolin, which may increase the risk
of surgical site infections; however, in this current study,
antibiotic prophylaxis was given prior to tourniquet inﬂa-
tion [31].
The beneﬁt of subcuticular soluble sutures or staples
remains a contentious issue, with a recent meta-analysis
suggesting an increased rate of superﬁcial SSI when wounds
were closed with staples compared with sutures [14]. In this
study, wound closure with staples was associated with an
increase in superﬁcial wound complications on univariate
analysis in the combined and hip arthroplasty cohorts, but this
difference was not observed upon multivariate analysis.
Therefore the question of optimal wound closure requires
further investigation.
Strengths of this study include an analysis of consecutively
operated patients over an 18-month period and a relatively
large sample size. A single researcher was responsible for all
data collection, classiﬁcation and coding, which promoted
consistency in the analysis. In addition, hospital care is
standardized for all arthroplasty patients at SVHM through
the protocol-driven clinical care pathway.
Limitations of the study are related to the retrospective
study design and the possible inaccuracy or misinterpretation
of the information contained in the medical records. However,
we attempted to address this by setting clear deﬁnitions of
wound complication prior to data collection. Secondly, not all
factors related to wound healing could be accounted for, such
as nutrition, hygiene and wound care, particularly after patients
were discharged home from hospital. Finally, we included data
regarding prosthetic joint infection; however, given the
contemporaneous setting of this study, 12- and 24-month
follow-up data for some patients are incomplete, therefore
some delayed and late infections may not be captured.
Superﬁcial wound complications, however, are a more typical
feature of early prosthetic joint infection rather than delayed
or late infection (where pain is the predominant clinical
feature) [3].
Conclusions
This study has identiﬁed unique factors in the evolution of
superﬁcial wound complications. These data provide clinicians
with evidence to support pre-emptive strategies to identify
patients at risk of superﬁcial wound complications, particularly
obese patients or patients with rheumatoid arthritis. This
study has highlighted the importance of perioperative factors,
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including skin preparation, tourniquet time and blood trans-
fusion, in the development of superﬁcial wound complications.
This study provides an impetus for further clinical research,
particularly assessing the impact of modiﬁcation of these
identiﬁed factors on the subsequent development of both
superﬁcial wound complications and subsequent prosthetic
joint infections.
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